Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZODIAC: Vandetanib + Docetaxel in Advanced NSCLC
NCT00312377Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2006
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 25
01
Overview
A Phase 3 trial of vandetanib in non-small cell lung cancer (NSCLC), sponsored by Sanofi. Started May 2006; status: completed.
02
Drugs
vandetanib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00312377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00312377.